Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker(Bayer (Germany)), Giuseppe Rosano(St George's Hospital), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Gianluigi Savarese(Karolinska Institutet), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), John R. Teerlink(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), Amina Rakisheva(Esteve Química (Spain)), Gerasimos Filippatos(National and Kapodistrian University of Athens), Maurizio Volterrani(Vita-Salute San Raffaele University), Mariantonietta Cicoira(Azienda Ospedaliera Universitaria Integrata Verona), Stephan von Haehling(German Centre for Cardiovascular Research), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Enrico Agabiti‐Rosei(MultiMedica), Andrew J.S. Coats(The Heart Research Institute), Johann Bauersachs(Medizinische Hochschule Hannover), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Konstantinos Tsioufis(National and Kapodistrian University of Athens), William T. Abraham(The Ohio State University), Lars H. Lund(Karolinska University Hospital), Francesco Cosentino(Linköping University), Marianna Adamo(Surgical Specialties (Canada)), Ewa A. Jankowska(Wroclaw Medical University), Brenda Moura(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Vijay Chopra(Max Super Speciality Hospital), Petar Seferović, Javed Butler(Saint Luke's Health System), Yuhui Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shelley Zieroth(University of Manitoba), Ulf Landmesser(Deutsches Herzzentrum der Charité), José Luís Merino(Hospital Universitario La Paz), Wilfried Müllens(Ziekenhuis Oost-Limburg), Carsten Tschöpe(Deutsches Herzzentrum der Charité), Felicita Andreotti(Agostino Gemelli University Polyclinic), Jian Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Muhammad Usman(Dow University of Health Sciences), Markus S. Anker(Humboldt-Universität zu Berlin), Marco Metra(Vita-Salute San Raffaele University), Michael Böhm(Saarland University)
Cited by 187
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k